Tag: biosimilars

May 31, 2017 Off

Asia to be drug delivery technology market fastest-growing region

By Dino Mustafić

Drug delivery technology market grows from $1,179.20 billion to $1,669.40 billion at a CAGR of 7.2% from 2016-2021. Oral drug delivery segment is expected to account for the largest share while hospitals segment is expected to account for the largest share of the market and Asia is expected to be fastest-growing region.

April 8, 2016 Off

Biosimilars: More Treatment Options Are on the Way

By Dino Mustafić

As the medical market grows, the US Food and Drug Administration FDA has published a neat piece about biosimilars. Recently, FDA has approved a second biosimilar product—Inflectra (Infliximab-dyyb), a biosimilar to Remicade (infliximab)—and expects to approve other biosimilars in the future.